Federal Register / Vol. 69, No. 190 / Friday, October 1, 2004 / Notices 58915

the requirements of Section 4(b) of the 

Oceans Act of 2000, CEQ is accepting 

comments on U.S. Ocean Commission’s 

recommendations. Further instructions 

for submitting comments to the IOPG 

may be found at http://ocean.ceg.gov.

Dated: September 24, 2004. 

Philip Cooney, 

Chief of Staff, Council on Environmental 

Quality.

[FR Doc. 04–22031 Filed 9–30–04; 8:45 am] 

BILLING CODE 3125–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Institute for Occupational 

Safety and Health Advisory Board on 

Radiation and Worker Health 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following committee 

meeting:

Name: Advisory Board on Radiation and 

Worker Health (ABRWH), National Institute 

for Occupational Safety and Health (NIOSH). 

Subcommittee Meeting Time and Date:

9:30 a.m.–11:30 a.m., October 19, 2004. 

Committee Meeting Times and Dates: 1 

p.m.–4:15 p.m., October 19, 2004. 7 p.m.–

8:30 p.m., October 19, 2004. 8 a.m.–4 p.m., 

October 20, 2004. 

Place: The Westin St. Francis, 355 Powell 

Street, San Francisco, California 94102, 

telephone 415/397–7000, fax 415/774–0124. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 65 people. 

Background: The ABRWH (‘‘the Board’’) 

was established under the Energy Employees 

Occupational Illness Compensation Program 

Act (EEOICPA) of 2000 to advise the 

President, delegated to the Secretary of 

Health and Human Services (HHS), on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Board include providing 

advice on the development of probability of 

causation guidelines which have been 

promulgated by HHS as a final rule, advice 

on methods of dose reconstruction which 

have also been promulgated by HHS as a 

final rule, evaluation of the scientific validity 

and quality of dose reconstructions 

conducted by the National Institute for 

Occupational Safety and Health (NIOSH) for 

qualified cancer claimants, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort. 

In December 2000 the President delegated 

responsibility for funding, staffing, and 

operating the Board to HHS, which 

subsequently delegated this authority to the 

CDC. NIOSH implements this responsibility 

for CDC. The charter was issued on August 

3, 2001, and renewed on August 3, 2003. 

Purpose: This board is charged with (a) 

providing advice to the Secretary, HHS on 

the development of guidelines under 

Executive Order 13179; (b) providing advice 

to the Secretary, HHS on the scientific 

validity and quality of dose reconstruction 

efforts performed for this Program; and (c) 

upon request by the Secretary, HHS, advise 

the Secretary on whether there is a class of 

employees at any Department of Energy 

facility who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such radiation 

doses may have endangered the health of 

members of this class. 

Matters to be Discussed: Agenda for this 

meeting will focus on Program Status Reports 

from NIOSH and Department of Labor; 

Special Exposure Cohort Petition Process 

Procedures; Scientific Research Issues 

Update; Site Profile Reviews; Subcommittee 

Report and Recommendations; and Board 

working sessions. There will be an evening 

public comment period scheduled for 

October 19, 2004, and a public comment 

period at midday on October 20, 2004. The 

Subcommittee will convene on October 19, 

2004, from 9:30 a.m.–11:30 a.m. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: Larry 

Elliott, Executive Secretary, ABRWH, NIOSH, 

CDC, 4676 Columbia Parkway, Cincinnati, 

Ohio 45226, telephone 513/533–6825, fax 

513/533–6826. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry.

Dated: September 20, 2004. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–22044 Filed 9–30–04; 8:45 am] 

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004N–0166]

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Infant Feeding 

Practices Study II

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995.

DATES: Fax written comments on the 

collection of information by November 

1, 2004.

ADDRESSES: The Office of Management 

and Budget (OMB) is still experiencing 

significant delays in the regular mail, 

including first class and express mail, 

and messenger deliveries are not being 

accepted. To ensure that comments on 

the information collection are received, 

OMB recommends that comments be 

faxed to the Office of Information and 

Regulatory Affairs, OMB, Attn: Fumie 

Yokota, Desk Officer for FDA, FAX: 

202–395–6974.

FOR FURTHER INFORMATION CONTACT:

Peggy Robbins, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1223.

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

I. Background on the Infant Feeding 

Practices Study II

Under section 903(d)(2) of the Federal 

Food, Drug, and Cosmetic Act (21 U.S.C. 

393(d)(2)), FDA is authorized to conduct 

research and educational and public 

information programs relating to foods 

and devices. Under this authority, FDA 

is planning to conduct a consumer 

study about infant feeding and the diet 

of pregnant women and new mothers. 

The study will provide detailed 

information about foods fed to infants, 

including breast milk and infant 

formula; factors that may contribute to 

infant feeding choices and to 

breastfeeding success, including 

intrapartum hospital experiences, 

mother’s employment status, mother’s 

self confidence, postpartum depression, 

infant sleeping arrangements; and other 

issues of interest to FDA, including 

infant food allergy, and experiences 

with breast pumps. The study will 

measure dietary intake of pregnant 

women and new mothers. It will also be 

used as one component of an evaluation 

of the Department of Health and Human 

Services (HHS) National Breastfeeding 

Awareness Campaign.

A sample of pregnant women will be 

drawn from a commercial consumer 

opinion panel for a longitudinal study 

in which almost all data will be 

collected by mailed questionnaires. The 

sample design was chosen to maximize 

the response rate, which is critical for 

the success of a longitudinal study.